Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px
Document › Details

PharmaNet Development Group, Inc.. (3/1/10). "Press Release: George A. McMillan Joins PharmaNet Development Group as Chief Financial Officer". Princeton, NJ.

Organisation Organisation PharmaNet Development Group Inc.
  Group PharmaNet (Group)
Products Product drug development services
  Product 2 analytical services
Persons Person McMillan, George A. (PharmaNet 201003– CFO before Ze-Gen Inc COO + CFO)
  Person 2 McMullen, Jeffrey P. (PharmaNet 201003 CEO)
     


PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, announced today that George A. McMillan has joined the Company as Chief Financial Officer.

"We are pleased to have George join PharmaNet Development Group," commented Jeffrey P. McMullen, President and Chief Executive Officer. "He has proven experience in successfully driving financial management strategies and productivity improvement initiatives for both public and private organizations."

Mr. McMillan joins PharmaNet Development Group from Ze-Gen, Inc., a Boston-based renewable energy company, where he filled the dual role of Chief Operating Officer and Chief Financial Officer. Previously, George held the position of Chief Financial Officer, Chief Executive Officer, and Chief Operating Officer at diversified technology and services firms, including The Palladium Group, Inc., CMGI, Inc., BMG Direct (Bertelsmann A.G.), Renaissance Solutions, Eastern Exclusives and others.

Mr. McMillan has an A.B. in Economics from Stanford University and received his J.D. and M.B.A. from Harvard University.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 41 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.

Contact: Anne-Marie Hess
Phone: (609) 951-6842
Email: ahess@pharmanet.com

   
Record changed: 2016-03-19

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for PharmaNet (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px